Role evidence
Usage summary
Strongest role: Inclusion Required
Inclusion-required count: 20
Treatment-assignment count: 0
Stratification count: 0
Cdx Established Context
HER2 / ERBB2 expression
gastric cancer · Combination Therapy
HER2 / ERBB2 expression is flagged as cdx established context because public trials show inclusion required evidence in 21 contexts. FDA CDx context exists.
Threshold snippets
Fragmentation view
Threshold count: 5
Common snippets: MSI-H | dMMR | MSI-H
Threshold label: Moderate
FDA CDx context
Mapping summary
CDx label: Fda Cdx Context Exists
CDx maturity score: 5/5
Confidence: High
Patent-density signal
Diagnostic appendix
Signal count: 0
Recent signals: 0
Density label: Low
Source links
Evidence paths
https://clinicaltrials.gov/study/NCT02545504 | https://clinicaltrials.gov/study/NCT07689292 | https://clinicaltrials.gov/study/NCT03777657 | https://clinicaltrials.gov/study/NCT05671822 | https://clinicaltrials.gov/study/NCT05458219 | https://clinicaltrials.gov/study/NCT01743365 | https://clinicaltrials.gov/study/NCT04933227 | https://clinicaltrials.gov/study/NCT07385703 | https://clinicaltrials.gov/study/NCT06829797 | https://clinicaltrials.gov/study/NCT04603040 | https://clinicaltrials.gov/study/NCT05177133 | https://clinicaltrials.gov/study/NCT07692204 | https://clinicaltrials.gov/study/NCT05039944 | https://clinicaltrials.gov/study/NCT05002686 | https://clinicaltrials.gov/study/NCT03504397 | https://clinicaltrials.gov/study/NCT06587425 | https://clinicaltrials.gov/study/NCT07483567 | https://clinicaltrials.gov/study/NCT01630083 | https://clinicaltrials.gov/study/NCT06219941 | https://clinicaltrials.gov/study/NCT07584135 | https://clinicaltrials.gov/study/NCT03653507